A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment
- 1 July 2014
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 160 (1) , 65-71
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education of the People's Republic of China (20120101110009)
- National Key Research and Development Program of China (2012ZX10002-007, 2013CB531405)
- National Natural Science Foundation of China (81271810)
This publication has 29 references indexed in Scilit:
- IL-17–producing invariant NKT cells in lymphoid organs are recent thymic emigrants identified by neuropilin-1 expressionBlood, 2011
- Natural Killer T Cell–derived IL-17 Mediates Lung Ischemia–Reperfusion InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis BAntiviral Therapy, 2010
- Chronic hepatitis B: Update 2009 #Hepatology, 2009
- Osteopontin regulates development and function of invariant natural killer T cellsProceedings of the National Academy of Sciences, 2008
- Hepatitis B Virus InfectionNew England Journal of Medicine, 2008
- CD1d-restricted iNKT cells, the ‘Swiss-Army knife’ of the immune systemCurrent Opinion in Immunology, 2008
- Phenotypic and Functional Changes of Cytotoxic CD56posNatural T Cells Determine Outcome of Acute Hepatitis C Virus InfectionJournal of Virology, 2007
- Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damageJournal of Experimental Medicine, 2007
- Immunology of hepatitis B virus and hepatitis C virus infectionNature Reviews Immunology, 2005